BackInvex Therapeutics Overview

Invex Therapeutics Current Assets

Invex Therapeutics's current assets is $4.1M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$4.06M
↓ 25.68% YoYΔ $-1.40M vs prior year quarter

Peer trimmed avg / median

Loading

Invex Therapeutics Current Assets History

Loading

Invex Therapeutics vs. peers: Current Assets Comparison

Loading

Invex Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Invex Therapeutics (IXC.AX) FAQ

Invex Therapeutics (IXC.AX) currently reports a current assets of $4.1M as of June 2026. That compares with $5.5M in the prior-year period — down 25.7% year over year. Use the charts on this page to explore Invex Therapeutics's current assets history and peer comparisons.

Invex Therapeutics's current assets decreased from $5.5M to $4.1M — a 25.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Invex Therapeutics reported $4.1M in current assets as of June 2026. That compares with $5.5M in the prior-year period — down 25.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $4.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Invex Therapeutics, and consider following IXC.AX for alerts when major investors trade the stock.

Invex Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $4.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IXC.AX with unrelated industries.